L. M. Blanco-Colio, J. L. Martin-Ventura, E. de Teresa, C. Farsang, A. Gaw, G. Gensini, et al., “Elevated ICAM-1 and MCP-1 Plasma Levels in Subjects at High Cardiovascular Risk Are Diminished by Atorvastatin Treatment. Atorvastatin on Inflammatory Markers Study: A Substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration,” American Heart Journal, Vol. 153, No. 5, 2007, pp. 881-888. doi:10.1016/j.ahj.2007.02.029

has been cited by the following article:

• TITLE: Anti Inflammatory Effects of Statins in Cardiac Surgery Patients

  AUTHORS: A. Raza, S. Kennedy, Y. Fan, B. Maher, M. Codd, T. Murphy, A. Wood, W. Watson

  KEYWORDS: Statins; Neutrophils; Cardiac Surgery; Outcome; TNF-α; sICAM-1

  JOURNAL NAME: World Journal of Cardiovascular Surgery, Vol.2 No.3, September 21, 2012

  ABSTRACT: Objectives: Cardiac surgery with cardiopulmonary bypass provokes systemic inflammatory response, which may cause organ dysfunction. Studies have suggested that pre-operative statin therapy can reduce morbidity and mortality associated with cardiac surgery; the mechanism for this remains unclear. We hypothesise that underlying mechanism of action for these effects of statins is through inhibition of neutrophil transendothelial migration. Methods: We recruited 151 patients undergoing cardiac surgery. Of these 41 patients were on no-statin; 48 patients on low-dose (10 - 30 mg) and 62 patients were on high-dose statin (40 - 80 mg). Ex vivo neutrophil migration was performed on pre-operative blood samples of 90 patients. Of these 90 patients we used 36 patients to assess the levels of TNF-α and sICAM-1. Clinical parameters of total 151 patients were assessed to analyse outcome. Results: Ex vivo neutrophil migration was decreased in high-dose statin group when compared to neutrophils isolated from no-statin or low-dose statin groups (p